ZURICH (Reuters) -Swiss ministers have met with senior executives of pharmaceutical companies Roche and Novartis to discuss ...

The Swiss government is due to meet this week with pharmaceuticals firms that U.S. President Donald Trump has asked to lower ...

Roche (OTCQX:RHHBY) and Novartis (NYSE:NVS) are scheduled to meet with Swiss government officials this week amid U.S.

President Donald Trump’s announcement about tariffs on pharmaceutical goods imported to the United States is delayed. | ...

Swiss ministers met with senior executives from Roche and Novartis to discuss the potential impact of U.S. import tariffs on pharmaceuticals. While pharmaceuticals currently avoid these tariffs, an ...

President Trump sees Switzerland as doing too little to address its trade deficit with the U.S., a gap he focused on as he ...

The Swiss government is engaging with pharma companies Roche and Novartis to address U.S. President Trump's demand for price cuts and to negotiate a 39% tariff on Swiss exports. The discussion follows ...

AFTER the European Union (EU), it’s now Switzerland’s turn to bemoan humiliation and surrender at the hands of the Trump ...

Switzerland’s government has reached out to local drugmakers Roche Holding AG and Novartis AG to discuss the tariff situation ...

Goods shipped from the country face a 39 percent tariff in the U.S., which companies warn will have dire consequences if ...

STORY: European shares ended three straight sessions of declines Monday (August 4) and recovered some ground from Friday's ...